🇺🇸 FDA
Patent

US 12195453

Antiproliferation compounds and uses thereof

granted A61PA61P35/00

Quick answer

US patent 12195453 (Antiproliferation compounds and uses thereof) held by Vertex Pharmaceuticals Incorporated expires Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jan 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61P, A61P35/00